- Home
- HLNE
as 03-07-2025 4:00pm EST
Hamilton Lane Inc is a private market investment solutions provider in the United States. It works with its clients to conceive, structure, build out, manage and monitor portfolios of private markets funds and direct investments, and it helps them access a set of such investment opportunities around the world. The company offers a range of investment solutions across a range of private markets, including private equity, private credit, real estate, infrastructure, natural resources, growth equity, venture capital and impact. The company generate revenues mainly from management and advisory fees.
| Founded: | 1991 | Country: | United States |
| Employees: | N/A | City: | CONSHOHOCKEN |
| Market Cap: | 6.0B | IPO Year: | 2017 |
| Target Price: | $163.00 | AVG Volume (30 days): | 610.7K |
| Analyst Decision: | Hold | Number of Analysts: | 7 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.42 | EPS Growth: | 66.80 |
| 52 Week Low/High: | $103.42 - $203.72 | Next Earning Date: | 02-04-2025 |
| Revenue: | $691,656,000 | Revenue Growth: | 41.16% |
| Revenue Growth (this year): | 25.46% | Revenue Growth (next year): | 8.07% |
Stock Insider Trading Activity of Hamilton Lane Incorporated (HLNE)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Rogers Hartley R. | HLNE | Executive Co-Chairman | Feb 12 '25 | Sell | $159.00 | 10,255 | $1,630,545.00 | 0 |
Latest Hamilton Lane Incorporated News
HLNE Breaking Stock News: Dive into HLNE Ticker-Specific Updates for Smart Investing
Argus Research
5 days ago
HLNE: Lowering target price to $154.00
PR Newswire
7 days ago
Hamilton Lane Launches Private Secondary Fund in the U.S., Further Expanding Global Evergreen Platform
Argus Research
12 days ago
HLNE: Lowering target price to $162.00
Private Banker International
14 days ago
Hamilton Lane opens new office in Dubai
Business Wire
17 days ago
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology
Argus Research
19 days ago
HLNE: Raising target price to $167.00
MT Newswires
a month ago
Hamilton Lane Prices $252 Million Public Offering
PR Newswire
a month ago
Hamilton Lane Announces Pricing of Public Offering of Class A Common Stock
Compare HLNE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HLNE Hamilton Lane Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.